new HIV med called Kaletra

October 2000

Abbott is now marketing a new HIV med called Kaletra.

It contains TWO protease inhibitors...lopinavir plus a low dose of ritonavir (Norvir).

Lopinavir gives Kaletra its antiviral activity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Disease management by pharmacists
Asthma Pulmicort Respules, the first corticosteroid solution for nebulizers
Asthma Most kids with asthma DON'T get a flu shot
Obesity & Weight Loss metformin for weight loss
new uses for the atypical antipsychotics
Inversine (mecamylamine) for Tourette's and other neurological disorders
Thyroid Disorders new brand of levothyroxine called Unithroid
how long they have to avoid grapefruit juice if they take certain drugs
Coenzyme Q10 is often recommended for patients on statins
herbs and supplements that can interact with prescription drugs
Breast Cancer Arimidex (anastrozole) is now approved as FIRST-LINE therapy of advanced or metastatic breast cancer
Infectious Diseases Levaquin (levofloxacin) will come in a new 750 mg strength
Infectious Diseases new HIV med called Kaletra
Cardiology watch for drug interactions with the new antiarrhythmic, Tikosyn (dofetilide)
soy and isoflavone supplements
Dermatology stronger restrictions on giving Accutane (isotretinoin) to women
new uses for the atypical antipsychotics
Women's Health Mifeprex (mifepristone, RU-486) will be available next month
Infectious Diseases SINGLE DOSE of Zithromax (azithromycin) for acute otitis media